May & Baker profit up 42% to N1.5bn in 2022
May & Baker, a pharmaceutical firm operating in Nigeria recorded a 42 percent jump in profit after tax to N1.5...
May & Baker, a pharmaceutical firm operating in Nigeria recorded a 42 percent jump in profit after tax to N1.5...
May & Baker, a manufacturer, and distributor of pharmaceutical products in its recently released nine-month financial results for the period...
For the business year ended December 31, 2021, May &Baker Nigeria Plc, a leading drug manufacturer grew its revenue by...
Nigeria’s leading pharmaceutical company, May & Baker Nigeria Plc recorded impressive performance in the third quarter (Q3) as improving sales...
In our last coverage of drug maker, May & Baker plc, “Sustaining the path of profitability amid economic headwinds, cashstrapped...
In our last coverage of drug maker, May & Baker plc, “Sustaining the path of profitability amid economic headwinds, cash-strapped...
Listed pharmaceutical firm May & Baker Nigeria Plc turned the corner in the fourth quarter of 2019 to push its...
May & Baker Nigeria has announced a contract manufacturing agreement to produce four brands of French pharmaceuticals Sanofi, a deal...
The revenue of drug maker, May & Baker, dropped 38.05 percent to N5.91billion in the third quarter of 2019 from...
Buy pressures from investors willing to take advantage of the cheap valuation of May & Baker Nigeria Plc, Nigeria’s first...